Outcome of Board Meeting

August13, 2026 The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai –400051 Dear Sir/ Madam, Trading Symbol: ZOTA Sub: Outcome of Board Meeting held on Thursday, August 13, 2026 Ref.: Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the captioned subject;we,M/s Zota Health Care Limited (the “Company”),would like to inform you that the Board of Directors of the Company in its Meeting held on Thursday, August 13, 2026 at 05:00 P.M. at Zota House, Bhagwan Aiyappa Complex, Next to Batliboi, Udhna-Navsari State Highway, Surat – 394210, Gujarat, have inter alia, discussed and approved the following businesses: 1. Considered and approved Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30, 2026along with the Limited AuditReport thereon. Financial Results and Limited AuditReport are enclosed herewith (Annexure-1). We would like to inform you that M/s. Pradeep K. Singhi & Associates, Chartered Accountants, Statutory Auditors of the Company, have issued the Limited Audit Report with Unmodified review conclusion. Further, Standalone and Consolidated Unaudited Financial Results for the period as aforementioned shall be available on the website of the Stock Exchange where the shares of the Company are listed i.e. at www.nseindia.com and on Company’s website at www.zotahealthcare.com. The Board meeting concluded at 6:05P.M. This is for your information and record. Thanking you, Yours faithfully, For Zota Health Care Limited Ashvin Variya (Group Company Secretary & Compliance Officer) Place: Surat Encl.: a/a Registered Office: Zota House, 2/896, Hira Modi Street, Sagrampura, Surat-395002 Ph: +91 261 2331601 Email: info@zotahealthcare.com Web: www.zotahealthcare.com CIN: L24231GJ2000PLC038352 Pradeep K Singhi & Associates CHARTERED ACCOUNTANTS Independent Auditor’s Review Report on Quarterly Unaudited Standalone Financial Results of the Company Pursuant to the Regulations 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended The Board of Directors of Zota Health Care Limited We have reviewed the accompanying statement of Standalone Unaudited Financial Results of Zota Health Care Limited (the “Company”) for the quarter ended June 30, 2026 (“the Statement”) attached herewith, being submitted by the Company pursuant to requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time (the “Regulations”). Management’s Responsibility This Statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review. Auditor’s Responsibility We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. Conclusion Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with applicable Indian accounting standards and other recognized accounting practices and policies has not disclosed the A/401, President Plaza, Near R.T.O. Office, Ring Road, Surat -395001 PH. No. 2474714 / 2474954 E-mail: info.surat@pradeepsinghi.com Pradeep K Singhi & Associates CHARTERED ACCOUNTANTS information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement. For Pradeep K Singhi & Associates Chartered Accountants FRN : 0126027W Date: 13-08-2026 Pradeep Kumar Singhi Place: Surat (Partner) M.No. 200/024612 UDIN: 26024612XVXFSJ1864 A/401, President Plaza, Near R.T.O. Office, Ring Road, Surat -395001 PH. No. 2474714 / 2474954 E-mail: info.surat@pradeepsinghi.com ZOTAH EAi.THCARE LIMITED --I-IJ UnauditSedt andFallonnea Rndaeslu lts tfhoqeru arteendedr 30th Jun2e02,6 • (AmouIntlan" kh s) � QuartEernded YeaErnd ed healtlhtcda.Prea rticu lars 30-06-26 31--03-26 30-06-2S 31--03-26 (Unaudited)( Audited) (Unaudi(tAeudd)it ed} I. RevefnruoOemperat ions 12702.911 2070.05 7800.704 0700.72 II.O thIenrc ome 394.26 410.33 223.391 340.18 I.l lTotIanlc ome 13097.17 12480.38 8024.09 42040.91 IV. Expenses: CoosftM ateCroinaslusm ed 236.97 360.44 490.521 746.43 PurchoafSs teosc k-in-Trade 7704.85 8930.203 442.2213 674.65 ChanignesI nventoorfFi iesn isGhoeodds W,o rt-in-Parnogdr ess Stock-in-Trade (830.13)( 2385.935)3 6.90( 2550.99) EmployeeE xBpeennsesefit 1238.95 1548.10 997.584 889.32 FinaCnocset s 29.86 8.34 3.68 25.26 Deprec/Ai maotrtiiosnaantDdie opnl eEtxipoenn se 126.88 125.33 79.68 395.43 OthEexrp enses 4329.54 3082.76 1618.969 785.45 Total Expenses 12836.921 1669.23 7169.543 7965.54 V. ProbfeiftEo xrceept iiotneaamsln t da fxr ocmo ntionpeuriatniogn s (ill-IV) 260.25 811.15 854.564 075.36 VI. ExcepIttieomnsa l (98.96) (9.986) VII.P rofrbefto/r(tela oxs s) 260.25 712.19 854.563 976.40 VIIIT.a Exx pense: (1C)u rrteanxt 75.99 264.00 223.68 1095.36 (1.t1.&)TD .DT aPxr ovCisrieoanSt heodert/ x cess 0.00 (10.95) (2D)e feTrarxe d 5.46 160.69 (40.44()1 01.34) IX. Pro(fLiotfs/ots rh)pe e r ifordo Cmo ntinuing Opera(tViUo-nVsI II) 189.72 608.87 590.44 2790.66 X. Profibte/f(tolarofxesr sod)mi sconotpienruaetdi ons XI. TaExx peonfds ies conOtpienruaetdi ons XII.P ro(fiLto/fs rsoD)misc ontiOnpeureadt (iaofnTtsaxe )r (X-XI) XIIIP.r rot(f/L osfsorthe) period 1s9.n 608.87 590.44 2790.66 XIV.Ot heCro mprehensive Income A (iI)t etmhswa itnl olbet r eclastsoiS ftiaetdeo mfe nt proafnidt loss (34.60) 31.02 (16.09) 50.81 (iIin)c oTmarexe lattoii tnetgmh swa itnl olbt e reclatsoSs tifatemenited ofp roafnrldtoss 8.71 (7.81) 4.05 (12.79) B( iI)t etmhswa itbel rlecl assitfoSi teda teomfpe rnofrtt anldo ss (iIin)c oTmarexe lattoii tnetgmh swa itbl erl e classified top roafnrldtos s - - Othceorm prehienncsofimotverhe p e e rinoetod ft, a x (25). 90 23.21 (1.204) 38.02 Totcaolm prehenIsncomei vef ort hpeeri od( X+IX IIIV ) 163.82 632.09 578.40 2828.68 PaidE-quuSpih taycr aepit al 3463.26 3463.26 2976.663 463.26 OthEeqru ity 85356.94 Earninegqsus ihpetaryor ffae c vea loufe1f 0each (1B)a s(iifcn) 0.55 1.77 2.03 8.48 (2D)i lu(tifen)d 0.55 1.77 1.88 8.48 denoftiegslu esrtsesh aaln a kh Foarn odn be haolfthef Board ForPradee p IC.S ln&gAs hsioc iates CharteAcredc ountants �<61� � FirmN o0.1 26027W (WhoTliemD ei rector()M anagiDnigrect or) PRADEEPDPRi Ag Dis KEti UEag MPlbn AS lye RIy d N GHI HimanMs.Zotah u MoxesICh.Zola KUMASRI N�G:H2:!I� ���:��� (D:i0 n1 097n2) (Di:n0 7625219) PradeKeupm Sairn gh! (Partner) M.N o2.00 /024612 GroCSu p Q�� � AshVvianrly a ViraMla ndviwala Dat1e3:-08- 2026 Pla:Sc uera t RegisteOrffiedce : Plant: ZotHao us2/e8,9 6H,i rMao dSitr eet Plonto1 .6 9S,u raSt� c(Eaclo nomZiocn e, SagrampSuurra-a,3t 9 50 02IP h+:9 21 6213 31601 NrS.a chRiani lwSatya tiSoanc,h in, Emaiiln:f o@zotahealthcare.com Sura-3t9 42 30( GuIjn.d)i a W [Showing first 8,000 characters — download PDF for full document]